4,336 results match your criteria: "Charing Cross Hospital.[Affiliation]"
J Plast Reconstr Aesthet Surg
December 2023
Guy's and St Thomas's NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, UK. Electronic address:
Objectives: To assess the expected duration of exposure of United Kingdom urology and plastic surgery trainees to the provision of gender affirming healthcare to transgender patients. This observational, cross-sectional survey asked UK training programme directors (TPDs) to report the volume of training in gender affirming care of transgender patients that urology and plastic surgery trainees are expected to receive.
Methods: A Google Form online questionnaire was distributed to each regional TPD in the UK both for plastic surgery and urology.
Med Leg J
December 2023
Medico-Legal Society, UK.
Eur Urol
January 2024
Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery & Interventional Science, University College London, London, UK. Electronic address:
Background: The role of multiparametric magnetic resonance imaging (MRI) for detecting recurrent prostate cancer after radiotherapy is unclear.
Objective: To evaluate MRI and MRI-targeted biopsies for detecting intraprostatic cancer recurrence and planning for salvage focal ablation.
Design, Setting, And Participants: FOcal RECurrent Assessment and Salvage Treatment (FORECAST; NCT01883128) was a prospective cohort diagnostic study that recruited 181 patients with suspected radiorecurrence at six UK centres (2014 to 2018); 144 were included here.
J Sci Med Sport
November 2023
Academic Department of Military Medicine, Defence Medical Services, UK; Carnegie School of Sport, Leeds Beckett University, UK.
Objectives: To assess how biomarkers indicating central nervous system insult (neurobiomarkers) vary in peripheral blood with exertional-heat stress from prolonged endurance exercise.
Design: Observational study of changes in neuron specific enolase (NSE), S100 calcium-binding protein B (S100β), Glial Fibrillary Acid Protein (GFAP) and Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) at Brighton Marathon 2022.
Methods: In 38 marathoners with in-race core temperature (Tc) monitoring, exposure (High, Intermediate or Low) was classified by cumulative hyperthermia - calculated as area under curve of Time × Tc > 38 °C - and also by running duration (finishing time).
Cureus
August 2023
Radiology, Conquest Hospital, East Sussex Healthcare NHS Trust, St. Leonards-on-Sea, GBR.
Chronic mesenteric ischemia (CMI) is uncommon and accounts for approximately 5% of cases. CMI presents with non-specific symptoms, making it difficult to diagnose, and requires complex management involving interprofessional teams. We present the case of a 66-year-old female who presented with postprandial abdominal pain, vomiting, sitophobia, and weight loss.
View Article and Find Full Text PDFUltraschall Med
February 2024
Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Dynamic contrast-enhanced ultrasound (DCE-US) is a technique to quantify tissue perfusion based on phase-specific enhancement after the injection of microbubble contrast agents for diagnostic ultrasound. The guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) published in 2004 and updated in 2008, 2011, and 2020 focused on the use of contrast-enhanced ultrasound (CEUS), including essential technical requirements, training, investigational procedures and steps, guidance regarding image interpretation, established and recommended clinical indications, and safety considerations. However, the quantification of phase-specific enhancement patterns acquired with ultrasound contrast agents (UCAs) is not discussed here.
View Article and Find Full Text PDFCureus
August 2023
Gastroenterology, Conquest Hospital, East Sussex Healthcare NHS Trust, St Leonards-on-Sea, GBR.
Choledocholithiasis has been defined as the presence of stones within the common bile duct (CBD) with up to one-half of the cases remaining asymptomatic. We report a case of an 84-year-old frail male admitted for the treatment of pneumonia, pleural effusion, and bacteraemia with co-incidental deranged liver function tests (LFTs). Ensuing magnetic resonance cholangiopancreatography (MRCP) noted three CBD stones; however, the patient remained asymptomatic.
View Article and Find Full Text PDFEur Urol Focus
May 2024
Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Context: Recommendations regarding the management of penile size abnormalities and dysmorphophobia are important in guiding evidence-based clinical practice.
Objective: To present a summary of the 2023 European Association of Urology sexual and reproductive health evidence-based recommendations for the management of penile size abnormalities and dysmorphophobia.
Evidence Acquisition: A broad and comprehensive scoping exercise covering all areas of the guidelines was performed.
Gynecol Obstet Invest
June 2024
Department of Medical Oncology, Gestational Trophoblastic Disease Centre, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
J Clin Endocrinol Metab
January 2024
Department of Metabolism, Digestion and Reproduction, Imperial College, London W12 0NN, UK.
Curr Opin Endocrinol Diabetes Obes
December 2023
Section of Investigative Medicine, Imperial College London, Commonwealth Building, Hammersmith Hospital.
Gynecol Oncol Rep
October 2023
Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
Introduction: Gestational trophoblastic neoplasia (GTN) including choriocarcinoma (CC) frequently requires multi-agent chemotherapy to achieve cure. In chemotherapy-resistant GTN, immunotherapy with the checkpoint inhibitors pembrolizumab, avelumab and camrelizumab are potential new treatment options previously described in small case series, phase 2 trials and case reports.
Case Description: A 32-year-old woman was diagnosed with gestational choriocarcinoma (FIGO score 5).
Clin Exp Dermatol
November 2023
Department of Dermatology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
BJOG
February 2024
West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial College NHS Trust, London, UK.
J Neurol
December 2023
Neuroradiology, Department of Imaging, Charing Cross Hospital, Imperial College London, NHS Healthcare Trust, London, UK.
Background: Mechanical thrombectomy (MT) remains an effective treatment for patients with acute ischemic stroke receiving oral anticoagulation (OAC) and large vessel occlusion (LVO). However, to date, it remains unclear whether MT is safe in patients on treatment with OAC.
Aims: In our study, we performed a propensity-matched analysis to investigate the safety and efficacy of MT in patients with acute ischemic stroke receiving anticoagulants.
Neurol Neuroimmunol Neuroinflamm
November 2023
From the Charing Cross Hospital (A.J.); Department of Radiology (T.B.), Imperial College Healthcare NHS Trust, London, United Kingdom; Department of Surgery and Cancer (L.D.), Faculty of Medicine, Imperial College London, United Kingdom; London North West University Healthcare NHS Trust (S.M.); Department of Brain Sciences (M.R.J.), Faculty of Medicine, Imperial College London; and Renal Department (J.A.P.T.), Imperial College Healthcare NHS Trust, London, United Kingdom.
Objectives: Leucine-rich glioma-inactivated 1 (LGI1) encephalitis and IgG4-related disease (IgG4RD) have traditionally been regarded as 2 distinct disease entities.
Methods: We detail the presentation, investigations, and management of a patient who showed typical signs and symptoms of LGI1 encephalitis and also found to possess pancreatic changes and a serum profile in keeping with IgG4RD.
Results: Serum and CSF analyses at presentation showed a significant hyponatraemia (117 mmol/L), elevated IgG4 concentration (1.
Actas Urol Esp (Engl Ed)
April 2024
IDENTIFY Study group.
Introduction: Malignant tumors of the urinary tract are associated with high morbidity and mortality, and their prevalence can vary worldwide. Recently, the IDENTIFY study has published results on the prevalence of urinary tract cancer at a global level. This study evaluates the prevalence of cancer within the Spanish cohort of the IDENTIFY study to determine whether the published results can be extrapolated to our population.
View Article and Find Full Text PDFJ Clin Med
July 2023
Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.
Objective: Due to an ever-increasing ageing population and limited available data around the use of thoracic endovascular aortic repair (TEVAR) in elderly patients, investigating its efficacy and safety in this age cohort is of vital importance. We thus reviewed the existing literature on this topic to assess the feasibility of TEVAR in elderly patients with severe thoracic aortic pathologies.
Methods: We identified all original research studies that assessed TEVAR in elderly patients published up to 2023.
Clin Exp Dermatol
November 2023
Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
BMJ Open
August 2023
Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK
Introduction: The top research priority for cavernoma, identified by a James Lind Alliance Priority setting partnership was 'Does treatment (with neurosurgery or stereotactic radiosurgery) or no treatment improve outcome for people diagnosed with a cavernoma?' This pilot randomised controlled trial (RCT) aims to determine the feasibility of answering this question in a main phase RCT.
Methods And Analysis: We will perform a pilot phase, parallel group, pragmatic RCT involving approximately 60 children or adults with mental capacity, resident in the UK or Ireland, with an unresected symptomatic brain cavernoma. Participants will be randomised by web-based randomisation 1:1 to treatment with medical management and with surgery (neurosurgery or stereotactic radiosurgery) versus medical management alone, stratified by prerandomisation preference for type of surgery.
Front Neuroimaging
February 2023
Department of Paediatric Oncology, Harley Street Children's Hospital, London, United Kingdom.
Aims: To determine an imaging protocol that can be used to assess the distribution of infusate in children with DIPG treated with CED.
Methods: 13 children diagnosed with DIPG received between 3.8 and 5.
Hell J Nucl Med
January 2024
Formerly, Melanoma Unit, Charing Cross Hospital, London UK.
Artificial Intelligence (AI) currently occupies the headlines in the media as well as the medical press, with messages of its emerging unlimited potential, but also tales of doom and gloom predicting risks for the extinction of humanity! One such headline in the London TIMES of 6 June 2023 reads: - "Two years to save the world, says AI adviser". To the uninformed, AI is nothing more than the processing of a colossal amount of data with lightning speed, now achievable with the latest spectacular developments in computing. However, could such power be harnessed to accurately predict the therapeutic potential of a new treatment emerging from Phase I, or Phase II trials, without the need to proceed to Phase III randomised, at times placebo controlled, trials? The deontological and ethical concerns about randomised trials have frequently occupied the medical literature as several clinical researchers feel uncomfortable with this kind of clinical research, especially when a placebo is allocated to patients with cancer, enlisted in a Phase III trial.
View Article and Find Full Text PDFJAMA Netw Open
August 2023
Nuclear Medicine Department, University Hospital of Brest, Brest, France.
Importance: Patients with head and neck squamous cell carcinoma (HNSCC) have a significant risk of locoregional recurrence within the first 2 years, with approximately two-thirds of patients experiencing such recurrence. While early recurrence detection may be associated with improved patient outcomes, the association of such detection with survival remains uncertain.
Objective: To investigate the association of an intensive posttreatment follow-up strategy using 18F-fludeoxyglucose-positron emission tomography with computed tomography (18FDG-PET/CT) with survival among patients with HNSCC.
Pharmaceuticals (Basel)
June 2023
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Despite receiving appropriate antiseizure medications (ASMs), a relevant percentage of neuropsychiatric patients do not benefit from this approach, and one reason is subtherapeutic ASMs plasma concentration (C(p)) due to improper drug adherence, interindividual pharmacokinetic differences, or metabolic interactions among different drugs. For these reasons, therapeutic drug monitoring (TDM) by measuring ASMs C(p) is an effective tool that improves pharmacological therapies in clinical practice. Based on these premises, in the present real-world study, we analyzed the C(p) of the most used ASMs in diverse medical conditions, which were assayed during the years 2018-2022 at the University Hospital of Pisa, including about 24,000 samples.
View Article and Find Full Text PDF